As part of the 2019-20 Community Pharmacy Quality Scheme, contractors were asked to complete a valproate audit, following Baroness Cumberlege’s report: First Do No Harm and the Medicines and Healthcare Regulatory Agency safety requirements for use of valproate in women and girls of childbearing age and trans men who are biologically able to be pregnant.

This report details the results and findings and makes recommendations on further actions to reduce preventable harm.